Literature DB >> 3619163

Myoglobin as an early indicator of acute myocardial infarction.

W B Gibler, C D Gibler, E Weinshenker, C Abbottsmith, J R Hedges, W G Barsan, M Sperling, I W Chen, S Embry, D Kereiakes.   

Abstract

The ECG and the determination of serum enzymes creatine phosphokinase (CPK) and lactate dehydrogenase (LDH) may be falsely normal early in acute myocardial infarction. Myoglobin, an oxygen-carrying protein found in cardiac muscle and striated skeletal muscle, presents an attractive alternative to CPK and LDH in the emergency department setting for identification of acute myocardial infarction. Myoglobin levels may be elevated in the serum within one hour after myocardial cell death with peak levels reached within four to six hours. We report a study of 59 patients presenting to a community hospital with chest pain and subsequent hospitalization. Twenty-one had an acute myocardial infarction. Presenting (0 hour) myoglobin determination was positive in 13 of 21 individuals, while CPK-MB was positive in only three. Serum myoglobin elevation at three hours identified all 21 patients with myocardial infarction with the CPK-MB determination positive in 19. Serum myoglobin elevation may permit early identification of myocardial infarction, with subsequent verification using CPK-MB determination, allowing appropriate intensive care admission for careful monitoring of these patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619163     DOI: 10.1016/s0196-0644(87)80521-8

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  13 in total

Review 1.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

2.  Diagnostic markers of acute myocardial infarction.

Authors:  Sabesan Mythili; Narasimhan Malathi
Journal:  Biomed Rep       Date:  2015-07-29

3.  Utility of cardiac troponin I, creatine kinase-MB(mass), myosin light chain 1, and myoglobin in the early in-hospital triage of "high risk" patients with chest pain.

Authors:  G S Hillis; N Zhao; P Taggart; W C Dalsey; A Mangione
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

4.  A prospective study of an algorithm using cardiac troponin I and myoglobin as adjuncts in the diagnosis of acute myocardial infarction and intermediate coronary syndromes in a veteran's hospital.

Authors:  A S Maisel; K Templin; M Love; P Clopton
Journal:  Clin Cardiol       Date:  2000-12       Impact factor: 2.882

5.  Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin.

Authors:  J Mair; E Artner-Dworzak; P Lechleitner; B Morass; J Smidt; I Wagner; F Dienstl; B Puschendorf
Journal:  Br Heart J       Date:  1992-11

Review 6.  An historical approach to the diagnostic biomarkers of acute coronary syndrome.

Authors:  Elisa Danese; Martina Montagnana
Journal:  Ann Transl Med       Date:  2016-05

7.  Biochemical assessment of acute myocardial ischaemia.

Authors:  M D Perez-Cárceles; E Osuna; D N Vieira; A Martínez; A Luna
Journal:  J Clin Pathol       Date:  1995-02       Impact factor: 3.411

Review 8.  Metabolic Pathway of Cardiospecific Troponins: From Fundamental Aspects to Diagnostic Role (Comprehensive Review).

Authors:  Aleksey M Chaulin
Journal:  Front Mol Biosci       Date:  2022-04-19

Review 9.  Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin.

Authors:  Pankaj Garg; Paul Morris; Asma Lina Fazlanie; Sethumadhavan Vijayan; Balazs Dancso; Amardeep Ghosh Dastidar; Sven Plein; Christian Mueller; Philip Haaf
Journal:  Intern Emerg Med       Date:  2017-02-11       Impact factor: 3.397

10.  Multiple imputation and analysis for high-dimensional incomplete proteomics data.

Authors:  Xiaoyan Yin; Daniel Levy; Christine Willinger; Aram Adourian; Martin G Larson
Journal:  Stat Med       Date:  2015-11-12       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.